Complement activation by recombinant adenoviruses
- 1 December 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (23) , 1794-1800
- https://doi.org/10.1038/sj.gt.3301611
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 34 references indexed in Scilit:
- Recombinant Adenovirus Gene Transfer in Adults with Partial Ornithine Transcarbamylase Deficiency (OTCD)Human Gene Therapy, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- A Phase I/II Study of Hepatic Artery Infusion with wtp53-CMV-Ad in Metastatic Malignant Liver TumoursHuman Gene Therapy, 1999
- The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypassCardiovascular Surgery, 1999
- C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationMolecular Immunology, 1999
- Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt traumaCritical Care Medicine, 1995
- The role of complement in inflammation and phagocytosisImmunology Today, 1991
- Complement activation and lung permeability during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1990
- Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndromeClinical and Experimental Immunology, 1990
- Human platelet activation by C3a and C3a des-arg.The Journal of Experimental Medicine, 1983